From the viewpoint of trial case doctors.

スポンサーリンク

概要

• 論文の詳細を見る
• 一般社団法人 日本臨床薬理学会の論文

著者

• 瀬戸 米蔵

  大阪臨床薬理研究所

• 東 純一

  大阪大学医学部

関連論文

• TXA_2受容体拮抗薬(BAY u 3405)の健常人における臨床薬理学的研究
• BIBR277カプセルの健常人における臨床第1相試験
• ビーグル犬の加齢による血中薬物動態の比較
• 抗高脂血症薬BAYw6228の健康成人および健康高齢者における臨床薬理学的研究
• KRN568の第1相臨床試験 : 単回投与試験
• 日本臨床薬理学会過去の演題を振り返って
• 臨床検査値に及ぼす生活環境因子の検討 : 日焼けの影響
• 臨床検査値に及ぼす生活環境因子の検討 : 太陽光曝露による生体内生理活性物質・情報伝達因子への影響
• カルシウム拮抗剤D600の高齢者と若齢者の薬物動態およびECGに及ぼす影響
• 臨床検査値に及ぼす生活環境因子の検討 : 日光暴露によるヒト免疫系への影響(第2報)
• 若年健常成人男子を対象とした第1相臨床試験における臨床検査基準値設定の1考察
• 5-リポキシゲナーゼ阻害薬(ABT-761)投与による血漿中濃度とロイコトリエン産生に対する検討
• 臨床検査値に及ぼす生活環境因子の検討 : 睡眠の影響
• アドリアマイシン心筋障害発現に対するタウリンの防御効果
• 心筋細胞における IL-6遺伝子の発現 : in situ hybridizationによる検討 : ポスター発表 : 第57回日本循環器学会学術集会
• 低酸素刺激による心筋細胞におけるIL-6の発現 : ポスター発表 : 第57回日本循環器学会学術集会
• TXA_2受容体拮抗薬(BAYu 3405)の健康高齢者における臨床薬理学的研究
• 臨床検査値の逸脱頻度と肥満度の関係
• 若年健常成人男子を対象とした第1相臨床試験における臨床検査基準範囲設定に際しての1考察
• 新術中電解質輸液剤の健常成人での生体反応に及ぼす影響
• 薬物体内動態修飾因子の検討 : 高齢被験者を対象として
• 肥大型心筋症(HCM)における心筋β型ミオシン重鎖(βMHC)遺伝子の解析 : 第58回日本循環器学会学術集会
• 家族性肥大型心筋症(HCM)の病因遺伝子の検討 : 心筋ミオシン重鎖(MHC)遺伝子を用いての解析 : 口述発表 : 第57回日本循環器学会学術集会
• IL-6の心筋細胞に対する作用とその細胞内情報伝達機構の検討 : ポスター発表 : 第57回日本循環器学会学術集会
• 臨床薬理比較試験について
• Clinical-pharmacological research on TXA2 receptor antagonist (BAYu3405) for healthy old people.
• Clinicopharmacological research of FK505 in normal subjects.
• Pharmacodynamics of orally administered acarbose in healthy volunteers and dose correlation of blood sugar and inhibiting actions of insulin elevation under oral disaccharide load.
• Pharmacodynamics of calcium antagonists D600 in the elderlies and in the young, and its effect on ECG.
• Phase 1 study of Recombinant human erythropoietin.Intravenous and repetitive subcutaneous admimistration test.
• Clinicopharmacological research of FK453 in normal subjects.
• Gallopamil の臨床薬理学的検討-第一相単回経口投与試験-
• 狂心発作寛解薬としての硝酸イソソルビドスプレー(E-100)の有用性-血圧降下作用と生物学的利用性からの検討-
• Changes in the Serum Enzyme Levels and the Predicting Factors during 2 Weeks Hospitalization in Healthy Male Volunteers: A Retrospective Study. Changes in Serum Levels of GOT,GPT,.GAMMA.-GTP,LDH,ALP and LAP.:Changes in Serum Levels of GOT, GPT, γ-GTP, LDH
• Pharmacodynamics in healthy adults of a new Class III antiarrhythmic agent E4031.
• タイトル無し
• Seasonal variation of IgE level and eosinophil count in healthy adult male.
• Study on serum GPT elevation in health adult male.GOT/GPT and relevance to body fatness.
• Evaluation of a new software for the personal computer "PAG-CP" for calculation of several pharmacokinetic coefficients.
• Method of calculation of left-right symmetric reliability area by conversion of logarithm, square root in biological equivalence test.
• A pharmacokinetic analysis method for sustained-release preparation.
• Phase I clinical studies with high dose of lisuride maleate. Incidence of appearance of subjective symptoms observed from method of administration.
• Clinical-pharmacological research of dopexamine in normal subject.
• Clinical-pharmacological study using in-urine potassium excretion amount in potassium pharmaceutical (MR9H2) administration as index.
• From the viewpoint of trial case doctors.
• Platelet aggregation ability in clinical phase I test. Variation in aggregation ability during adminisration of .ALPHA.-indobufen tablets.
• Pharmacokinetics in a healthy adult of a new Class III antiarrhythmic agent E4031.
• Consideration of clinical laboratory reference value setting in phase 1 clinical trial for healthy juvenile male adults.
• Reliability of occult blood test of feces in clinical laboratory.Appearance frequency of positive examples.
• Abnormal elevation of serum escape enzyme level by exercise load.
• Pharmacological study for oral administration of aldose reductase inhibitor, tolrestat.Effect on sorbitol level in erythrocyte.
• Examination of drug disposition kinetic modifying factor. Subject to old examinees.
• Studies on living environment factor influenced in clinical laboratory findings.Effect of sunburn.
• Comparison of blood pharmacodynamics by the aging of beagle dogs.
• Effect of living environment factors on laboratory findings.Effect of solar light exposure on in vivo biologically active substances and information transfer factors.
• Phase I study of HLBI prolonged action preparation. Comparative studies with rapid release preparation.
• Looking back on past subjects released in Japanese Soc. of Clinical Rharmacology and Therupeutics.
• Phase I clinical studies on recombinant human G-CSF (KRN8601). A study on its single administration by intravenous drip infusion.
• Phase I studies of a recombinant human G-CSF (KRN8601). Comparison between intravenous administration and subcutaneous administration.
• Studies on effect on regression of cardiac hypertrophy by prolonged administration of metoprolol in hypertensive patients.
• Circadian variation of data of laboratory tests in healthy adult men. Peripheral blood cell counts and platelet aggregation ability.
• Examination of influences of factors of living environment on results of clinical tests. Influences of sunlight exposure on human immune system. Second report.
• Effect of exercise test on a urinalysis.The urinalysis in producing muscular pain.
• Examination of exercising influence on laboratory finding.Effect of sleep.
• Reference Interval of Clinical Laboratory Data of Young Healthy Male Volunteer in the Phase I Clinical Study.
• 5. Examination on plasma concentration and leukotriene production by administration of lipoxygenase inhibitor (ABT-761).
• Studies on the choice of subjects in phase I clinical tests. Significance of sinus arrhythmia and sinus bradycardia.
• Variations in data of liver function tests by administration of placebo (single and consecutively). GOT, GPT and .GAMMA.-GTP.

もっと見る 閉じる

スポンサーリンク